Ann: Grant of US Patent For Fondaparinux Manufact, page-3

re: Ann: Grant of US Patent For Fondaparinux ... PS made a cheeky comment at AGM last year about the capital raising, saying that although there will be dilution, in the big scheme of things it means ACL may be worth $13 per share instead of $17/$18. No timelines with this comment but I guess if Hyact is successful and this comes to fruition, we'll all be meeting at the luxury car dealers instead of the local bar.

I'm in for the long haul and happy to take dividends along the way, by the time Hyact has a drug on the market my original outlay will be paid back without having to sell any shares - I really believe ACL is my ticket to no mortgage and me trading in the Mazda for a Magnum PI Ferrari (this is my 3 - 5 year plan). Gotta be in it to win it. I look forward to buying my mates a beer and saying "you can't say I didn't give you a heads up - wanna come for a spin to Byron with the roof off"